Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Surface Oncology Management to Present at the Solebury Trout Class of 2018 Biotech IPOs Investor Day | ||
By: Nasdaq / GlobeNewswire - 24 Apr 2019 | Back to overview list |
|
CAMBRIDGE, Mass., April 24, 2019 (GLOBE NEWSWIRE) -- Surface Oncology (NASDAQ:SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today announced that Jeff Goater, chief executive officer, will be participating and presenting a corporate update at the Solebury Trout Class of 2018 Biotech IPOs Investor Day, hosted together with Davis Polk and BMO Capital Markets. The company will be closing the NASDAQ market as part of the conference on Thursday, April 25th. Presentation details: A live and archived webcast of the presentation can be accessed by visiting the Investors page of the website at https://investors.surfaceoncology.com/news-events/events. About Surface Oncology: Contacts: Krystle Gibbs |
||
|
||
Copyright 2019 Nasdaq / GlobeNewswire | Back to overview list |